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NK cells are the effector lymphocytes of the 
innate immune system (Vivier  et al., 2008). 
They  can  recognize  and  spontaneously  kill 
transformed or infected cells, a function which 
is regulated by the integration of a multitude 
of signals from both inhibitory and activating 
germline-encoded NK cell receptors (NKRs). 
NK  cells  have  several  cellular  recognition   
mechanisms to distinguish between self and 
non-self (Lanier, 2005, 2008b). For one, they 
preferentially eliminate target cells that do not 
express normal levels of self-molecules, such as 
the highly polymorphic MHC class I proteins 
(H-2 class I in mice). Under normal circum-
stances, these molecules interact with inhibitory 
NKR, including the killer cell immunoglobu-
lin-like receptors (KIRs) in humans and Ly49 
receptors in rodents. Consequently, the target 
cell is recognized as self and no killing occurs, 
as ligand binding promotes the recruitment of 
phosphatases  via  an  immunoreceptor  tyro-
sine–based inhibition motif in the cytoplasmic 
tails of the receptors, generating an inhibi-
tory signal. When surface expression of these 
self-molecules is disrupted, as is the case in 
some viral infections, the inhibitory signal is 
abrogated  and  the  target  cell  is  lysed. This 
method is known as “missing self” recognition 
(Ljunggren and Kärre, 1985). In parallel, the 
infection induces the synthesis of stress and 
viral proteins that are expressed at the cell 
surface, proteins which closely resemble self-
molecules or are associated with them. Some 
activating NKRs are able to bind these stress 
molecules, whereas others recognize viral pro-
teins as non-self. This recognition mechanism 
can be called “stressed self” or “altered self,” 
respectively. Activating  NKRs  lack  intrinsic 
signaling  activity  and  instead  associate  with 
adaptor  proteins  containing  immunorecep-
tor  tyrosine–based  activation  motifs,  such   
as  DAP10  or  DAP12,  which  initiate  signal 
transduction cascades leading to NK cell granule   
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Recognition of mouse cytomegalovirus (MCMV)–infected cells by activating NK cell recep-
tors was first described in the context of Ly49H, which confers resistance to C57BL/6 mice. 
We investigated the ability of other activating Ly49 receptors to recognize MCMV-infected 
cells in mice from various H-2 backgrounds. We observed that Ly49P1 from NOD/Ltj mice, 
Ly49L from BALB mice, and Ly49D2 from PWK/Pas mice respond to MCMV-infected cells 
in the context of H-2Dk and the viral protein m04/gp34. Recognition was also seen in the 
H-2d and/or H-2f contexts, depending on the Ly49 receptor examined, but never in H-2b. 
Furthermore, BALB.K (H-2k) mice showed reduced viral loads compared with their H-2d or 
H-2b congenic partners, a reduction which was dependent on interferon  secretion by 
Ly49L+ NK cells early after infection. Adoptive transfer of Ly49L+, but not Ly49L, NK cells 
significantly increased resistance against MCMV infection in neonate BALB.K mice. These 
results suggest that multiple activating Ly49 receptors participate in H-2–dependent 
recognition of MCMV infection, providing a common mechanism of NK cell–mediated 
resistance against viral infection.
© 2011 Pyzik et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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abrogates this resistance (Sjölin et al., 2002; Cheng et al., 2008; 
Fodil-Cornu et al., 2008). In addition, B6 mice become sus-
ceptible to MCMV infection when challenged with a mutant 
MCMV virus lacking the m157 gene (Bubić et al., 2004). 
Notably, a second NK cell–dependent mechanism of resis-
tance to MCMV was found in MA/My mice. Indeed, the 
epistasis between the Ly49 and H-2 loci underlies this resis-
tance (Desrosiers et al., 2005). In this model, the activating 
Ly49P receptor requires both host H-2Dk molecule and viral 
m04/gp34 protein to mediate recognition of MCMV-infected 
cells (Kielczewska et al., 2009). These results indicate that in 
addition to Ly49H, the Ly49P receptor mediates resistance to 
MCMV infection yet through a different process. Therefore, 
it has prompted us to explore whether other Ly49-activating 
receptors share the ability to recognize MCMV infection in 
either a Ly49H or Ly49P manner.
In mice, a vast repertoire of Ly49 receptors has been 
described. To date, four Ly49 haplotypes have been com-
pletely elucidated by genomic sequence analysis (Carlyle   
et al., 2008). Out of 15 Ly49 genes, B6 mice possess two that 
mobilization, cytokine secretion, and ultimately the killing 
of the target cell (Lanier et al., 1998; Orr et al., 2009; Tassi   
et al., 2009).
The critical role of activating NKRs in viral infections has 
been best characterized in acute infection with mouse CMV 
(MCMV). As other members of the -Herpesviridae family, 
MCMV has evolved immune-evasion strategies that allow 
unrestricted viral replication in most inbred mouse strains 
during the early stage of infection (Scalzo et al., 1995). A few 
strains, however, are naturally resistant to MCMV infection. 
In particular, C57BL/6 (B6) mice express the Ly49H-activating 
receptor that binds to m157, a viral MHC class I homologue 
expressed at the infected cell surface during the early phase of 
infection. This event triggers NK cell activation and elimina-
tion of the infected cells (Arase et al., 2002; Smith et al., 2002). 
There is overwhelming evidence supporting the central role 
of  the  Ly49H–m157  axis  in  MCMV  resistance.  Indeed, 
Ly49H transgenesis into genetically susceptible mouse strains 
renders them resistant to MCMV. Conversely, knocking out 
the Ly49h or Dap12 genes in normally resistant animals 
Figure 1.  Several activating Ly49 receptors recognize an MCMV-infected cell based on the presence of the m04/gp34 viral peptide within 
a specific H-2 context. (A) Percentages (mean ± SD) of GFP expression by reporter cells carrying individual Ly49 receptors upon co-culture with MEF 
cells of the H-2f (top), H-2k (middle), or H-2d (bottom) haplotype under the following conditions: uninfected (), IFN- pretreated (200 U), or infected at 
an MOI of 0.5 with WT, m04, or m04m06m152 MCMV. (B) GFP expression by reporter cells carrying individual Ly49 receptors upon co-culture with 
H-2k MEF cells that are either uninfected (thin line) or WT MCMV infected (gray filled line) in the absence (top) or presence of H-2Dk or H-2Kk blocking 
antibody (middle) or isotype control (bottom). (C) Sequence alignment of the predicted H-2-binding region of Ly49 NKDs based on the Ly49A:H-2Dd crys-
tal structure. Conserved residues between the Ly49 receptors are shown as dashes. Secondary structure elements are denoted by loops (white rectangles) 
and -strands (gray ovals). Downward arrows represent putative MHC class I contact sites, whereas boxed residues delimit the NXT N-glycosylation motif. 
Residues in red represent amino acids unique in Ly49 receptors recognizing the infection in an m04/gp34–H-2–dependent manner. Sequences were re-
trieved from GenBank with the following accession nos.: Ly49DB6, AF349733.1; Ly49DNOD, AF218078.1; Ly49D1PWK, AY860975.1; Ly49L2BALB, AF204266; 
Ly49MNOD, AF283252.1; Ly49PMA/My, AY971807.1; Ly49P1NOD, AF218080.1; Ly49RMA/My, AF288377.1; and Ly49WNOD, AF283250.1. Results from one of at least 
three experiments are shown.JEM VOL. 208, May 9, 2011 
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the M2-tagged DAP12 adaptor protein. Equivalent Ly49 ex-
pression and functionality in reporter cells was assessed with 
-M2 antibody (unpublished data). Reporter cells were co-
cultured with a panel of mouse embryonic fibroblast (MEF) 
cells of different H-2 haplotype (H-2d, H-2k, H-2b, H-2q,   
H-2r, H-2f, H-2g7, H-2a, H-2PWK, and H-2/) under various 
conditions (Fig. 1 and Table I). As expected, Ly49H reporter 
cells  were  stimulated  by  MCMV-infected  MEFs  indepen-
dently of the H-2 background as a result of the presence of 
the viral molecule m157 on the surface of infected cells (Arase 
et  al.,  2002).  No  stimulation  was  observed  for  Ly49DB6-, 
Ly49DNOD-, Ly49MNOD-, Ly49RMA/My-, Ly49UMA/My-, and 
Ly49D1PWK-bearing 2B4 cells under any of the conditions 
tested (Table I). Ly49W1 reporter cells were stimulated MEF 
cells of H-2d, H-2k, or H-2f haplotype irrespective of the con-
dition tested (Fig. 1 A). In contrast, in addition to Ly49PMA/My, 
three other reporter cell lines, Ly49LBALB (Ly49L), Ly49P1NOD 
(Ly49P1), and Ly49D2PWK (Ly49D2), were stimulated both   
in an MCMV- and H-2–dependent fashion. However, the 
extent of functional recognition for each receptor was differ-
ent. Ly49P1-expressing cells were weakly stimulated by un-
infected or infected H-2d MEFs but responded robustly by 
MCMV-infected cells of the H-2k background. Ly49D2 re-
porters were only stimulated by infected H-2k MEFs. Ly49L 
reporter cell activation was MCMV dependent in multiple 
H-2 contexts, with the strongest activation observed in H-2f 
(60%), intermediate in H-2k (50%), and weak in H-2d  
(< 40%) contexts (Fig. 1 A).
To examine the role of the m04/gp34 molecule in recep-
tor recognition, reporter cells were co-cultured with MEFs 
infected with two different deletant MCMVs. The first dele-
tant  lacked  the  ORF  encoding  m04/gp34  alone  (m04), 
whereas the second lacked three ORFs encoding m04/gp34, 
m06/gp48, and m152/gp40 (m04m06m152; Fig. 1 A). 
The m06/gp48 and m152/gp40 products are immunoevasins 
that  down-regulate  MHC  class  I  expression  (Jonjić  et  al., 
2008).  Therefore, cells infected with mutant m04m06m152 
encode activating receptors (Ly49d and h). In contrast, the 
BALB/c strain has one activating receptor (Ly49l) out of 
seven  Ly49  genes.  In  129  mice,  three  activating  receptors 
(Ly49r, u, and p) can be found among 12 Ly49 genes. Con-
versely, 7 out of 21 Ly49 genes are activating in NOD/Ltj 
mice (Ly49d, u, p3, p1, w, m, and h; Carlyle et al., 2008). As 
opposed  to  their  inhibitory  counterparts,  rare  self-ligands 
have been described for activating Ly49 receptors (Ly49PNOD 
and Ly49DB6 can recognize H-2Dd, whereas Ly49WNOD can 
recognize both H-2Dd and H-2Dk; George et al., 1999; Silver 
et al., 2000, 2001). Although some are known to recognize 
viral proteins, many remain orphans.
In  this  paper,  we  demonstrate  that  the  Ly49LBALB-, 
Ly49P1NOD-, and Ly49D2PWK-activating receptors can recog-
nize MCMV-infected cells in an m04/gp34-specific H-2– 
dependent manner. Among them is a novel activating receptor 
isolated from the wild-derived mouse strain PWK/Pas. More-
over, the improved ability of BALB.K (H-2k) mice to control 
MCMV proliferation in the spleen relative to BALB/c (H-2d) 
or BALB.By (H-2b) mice is NK cell dependent. In addition, 
we show that it correlates with the specific expansion and 
IFN- secretion from Ly49L+ NK cells in these mice. Finally, 
the survival of neonate mice after MCMV infection is in-
creased upon adoptive transfer of Ly49L+ NK cells. These   
results suggest that the m04/gp34-specific H-2–dependent 
detection of infected cells by activating Ly49 receptors is a 
common mechanism of host defense, whereas Ly49H-m157 
recognition remains restricted to B6 mice.
RESULTS
Multiple activating Ly49 receptors recognize an MCMV-
infected cell based on the presence of the m04/gp34 viral 
peptide and of a specific H-2 context
Given the close relationship between MCMV and its host, we 
examined the ability of activating Ly49 receptors to respond 
to MCMV-infected cells in different H-2 contexts. For this, 
we cloned 13 activating Ly49 receptors into 2B4 cells expressing 
Table I.  Recognition of WT MCMV-infected cell by Ly49 receptors in different H2 contexts
Receptor Haplotype H2d H2k H2q H2b H2g7 H2a H2PWK H2r H2f H2/
C57BL/6 Ly49D          
C57BL/6 Ly49H +++ +++ +++ +++ +++ +++ +++ +++ +++ +++
MA/My Ly49P + ++    N.P.    
MA/My Ly49R          
MA/My Ly49U       N.P.   
BALB/c Ly49L + ++    ++   ++ 
NOD/Ltj Ly49D          
NOD/Ltj Ly49M       N.P.   
NOD/Ltj Ly49P1  +    +    
NOD/Ltj Ly49W1 +++ +++       +++ 
PWK/Pas Ly49D1       N.P.   
PWK/Pas Ly49D2  +        
+++, 100–70% GFP+ cells; ++, 69–40% GFP+ cells; +, 39–15% GFP+ cells; , <15% GFP+ cells; N.P., not performed.1108 NK cell–mediated resistance to MCMV | Pyzik et al.
three common features shared by four receptors that were 
identified beforehand. Those include a threonine to arginine/
methionine substitution at position 224 resulting in the loss 
of a glycosylation motif at position 221–223, as well as a con-
served leucine and asparagine residues at position 234 and 
244, respectively (Fig. 1 C). Whether and how these residues 
influence MCMV recognition remain to be established.
NK cell–mediated control of MCMV replication in BALB 
mice depends on H-2 haplotype
BALB mice possess the smallest described Ly49 repertoire, 
with only four Ly49 receptors expressed on mature NK cells 
(Ly49A, C, G, and L; Ortaldo et al., 1999; Van Beneden et al., 
2001; Gays et al., 2006). Moreover, the availability of BALB 
animals congenic for different H-2 loci offers the opportu-
nity to examine in vivo the role of Ly49L+ NK cells in H-2d, 
H-2b, or H-2k contexts. At a dose of 5 × 103 PFU, viral repli-
cation rapidly progressed in BALB.K (H-2k) mice, reaching 
Log10 5 ± 0.1 PFU at 2 d post infection (p.i.) However, start-
ing at day 4, viral load decreased, culminating at Log10 3 ± 0.2 
PFU by day 10 p.i. This reduction was not seen at the same 
level in BALB/c (H-2d) mice, which showed viral titers 50-fold 
higher than those of BALB.K mice by day 6 p.i. and were 
moribund by day 10 p.i. (Fig. 2 A). At the same dose, BALB. By 
(H-2b) mice succumbed between days 3 and 4 p.i. (not de-
picted); however, even upon infection with half the normal 
dose (2.5 × 103 PFU), they had a signifi-
cantly higher viral load than BALB.K mice 
by day 4 p.i. (Fig. 2, A and B). Interestingly, 
the  MCMV  viral  load  in  the  liver  of   
BALB.K mice was fourfold lower by day 4 
p.i. than in BALB.By mice (Fig. 2 B), yet 
the viral load difference between BALB.K 
and BALB/c mice only became significant 
MCMV express high levels of MHC class I molecules as   
opposed to WT or m04-infected cells (Fig. S1). Ly49H re-
porter cells were stimulated by MEFs infected with both WT 
and  MCMV  mutant  viruses.  Ly49W1  reporter  cells  were 
stimulated in all conditions, further demonstrating that their 
activation depends on the presence of H-2 molecules rather 
than MCMV viral proteins. In contrast, the absence of m04/
gp34 effectively reduced the activation of Ly49P1, Ly49D2, 
or Ly49L reporter cells even with high levels of MHC class I 
expression (Fig. 1 A). To examine the involvement of the 
MHC class I molecules, reporter cell assays were carried out 
in the presence of anti-H-2Dk, anti-H-2Kk, or control IgG 
antibodies (Fig. 1 B). Stimulation of the reporter cells was 
abolished specifically in the presence of anti-H-2Dk antibod-
ies, demonstrating that the ability of Ly49D2, Ly49P1, and 
Ly49L to recognize MCMV-infected cells depends on the 
presence of the H-2Dk molecule. Thus, we identified three 
additional haplotype-specific Ly49 stimulatory receptors that 
share a common H-2–dependent recognition mechanism of 
MCMV-infected cells with Ly49PMA/My 2B4 reporter cells 
involving the m04/gp34 viral protein and H-2Dk molecules.
Structurally, activating receptors that recognize MCMV-
infected cells conditional on their H-2 background belong to 
group II (because of the absence of predicted helix 3 within 
loop L3; Deng et al., 2008). The amino acid sequence align-
ment of their natural killer domain (NKD) regions revealed 
Figure 2.  Effective control of MCMV proliferation in BALB 
mice depends on the H-2 haplotype. (A) BALB.By (H-2b), BALB/c 
(H-2d), and BALB.K (H-2k) mice were infected with either 2.5 × 103 
PFU/mouse (BALB.By) or 5 × 103 PFU/mouse (BALB/c and BALB.K) 
of MCMV. Viral titers were assessed in the spleen at days 2, 4, 6, 
and 10 p.i. (B) Day-4 viral titers in the spleen and liver of BALB.By 
and BALB.K mice infected with 2.5 × 103 PFU/animal are shown. 
The data are presented as median viral titer ± interquartile range 
(IQR). The number of animals used at each time point is between 
4 and 12 and represents four pooled experiments.
Figure 3.  Effective early and late control of 
MCMV proliferation in BALB.K mice depends 
on NK cells, whereas CD8+ T cells become in-
volved later. (A and B) BALB.K mice were depleted 
of NK cells (top), CD8 T cells (bottom), or both  
(C) before WT MCMV infection. Viral titers were 
assessed at different time points p.i. in the spleen 
(A and B, top) and liver (A and B, bottom). The data 
represent three pooled experiments (median viral 
titer ± IQR) with three to four mice per experiment.JEM VOL. 208, May 9, 2011 
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increased  virus  titers  although  with  different  pat-
terns. The effect of NK cell depletion was seen from 
day 4 to 10 p.i. in the spleen, but it became apparent 
in the liver at later time points (days 6 and 10 p.i.;   
Fig. 3, A and B, top). In contrast, the effect of CD8+ 
T cell depletion was observed earlier in the liver 
(days 4 and 6) and later in the spleen (days 6 and 10) 
over the course of infection (Fig. 3, A and B, bottom). 
Interestingly, splenic viral titers continued to decrease 
over the course of the infection after either NK cell 
or CD8+ T cell depletion, demonstrating that both 
lymphocyte  populations  contribute  to  viral  clear-
ance from day 6 p.i. onward. Indeed, when both cell 
populations were depleted at the same time, a >100-
fold increase in viral titers was observed in all organs 
tested by day 6 p.i. and mice were moribund shortly 
after (Fig. 3 C and not depicted). CD4+ T cells have 
also been shown to play a role during the chronic 
phase of MCMV infection, especially in the salivary 
gland (Polić et al., 1998; Lee et al., 2009; Andrews   
et  al.,  2010). We  thus  depleted  BALB.K  mice  of 
CD4+ T cells and infected them with WT MCMV. 
At all time points p.i., the viral titers in the spleen 
and liver were equivalent in depleted and nonde-
pleted animals (Fig. S3, A and B). It is of note that the 
control of virus replication in BALB.By mice was not affected 
by the depletion of NK cells (Fig. S3 C). Thus, NK cells have 
a nonredundant role in the early control of spleen viral titer, in 
addition to contributing substantially to viral spread at later 
time points, in conjunction with CD8+ T cells.
Specific expansion of Ly49L+ NK cells during MCMV infection
Ly49H+ NK cell expansion is a hallmark of the NK cell re-
sponse in the prototype B6 MCMV-resistant strain. To examine 
the dynamics of NK cell subpopulations during infection, we 
starting at day 10 p.i. (Fig. S2). Therefore, BALB.K mice have 
an enhanced ability to control MCMV replication in the spleen 
and the liver compared with BALB.By or BALB/c animals, al-
though this ability becomes evident at different time points.
In BALB.K animals, NK or CD8+ T cells might be in-
volved in the control of viral replication (Yang et al., 1985; Ehl 
et al., 1996; Polić et al., 1998; Krmpotic et al., 2003; Sumaria 
et al., 2009). Injection of BALB.K mice with anti–asialo-GM1 
or with anti-CD8 antibodies, which preferentially deplete NK 
cells  or  CD8+ T  cells,  respectively,  resulted  in  significantly   
Figure 4.  H-2 and m04/gp34-specific proliferation of 
Ly49L+ NK cells in BALB mice during MCMV infection.  
(A) 2B4 reporter cells expressing Ly49 receptors from the BALB 
repertoire were stained with a panel of Ly49-specific antibod-
ies as well as with anti-M2 (DAP12) antibody. MFI is shown.  
(B) Freshly extracted splenocytes from BALB congenic mice 
were stained for NK cells and different Ly49 receptors. YE1/48 
and 12A8 antibody staining is shown. YE1/48 stains a double 
population of NK cells with either high or intermediate inten-
sity. The intermediate population is not stained by the anti-
Ly49A–specific clone (12A8) and represents the fraction of NK 
cells expressing the activating Ly49L receptor. BALB.By, BALB/c, 
or BALB.K mice were infected with WT or m04 MCMV. Their 
spleens were collected at different time points p.i. (C and D) The 
number of NK cells (C) and the percentages of Ly49A-, Ly49C-, 
Ly49G-, or Ly49L-positive NK cell fractions (D) were deter-
mined. Asterisks denote p-values <0.05. (E) Representative dot 
plots of Ly49A and Ly49L expression on NK cells from BALB.By, 
BALB/c, or BALB.K mice infected with WT MCMV at day 4 and  
6 p.i. Data are from three experiments (mean ± SD) with three 
to four mice per group. n/a, not available.1110 NK cell–mediated resistance to MCMV | Pyzik et al.
cells or lymphokine-activated killer cells (LAK cells) from 
BALB.K, BALB.By, or BALB/c was performed. All strains 
showed similar frequencies of Ly49A+ (10%), Ly49C+ (50%), 
Ly49G+ (22%), and Ly49L+ (15%) subpopulations (Fig. 4 B; 
and Fig. S4, A–C).
Upon MCMV infection, total NK cell numbers decreased 
in the three strains studied; however, the reduction was com-
paratively less pronounced in BALB.K mice, which had sig-
nificantly higher NK cell numbers over the course of infection 
(Fig. 4 C). The frequencies of Ly49A+, Ly49C+, and Ly49G+ 
NK cells remained similar in infected mice, except in the 
BALB.By strain. In these mice, the percentage of Ly49A+ NK 
cells increased from 10 to 18% of the total NK cell population 
by day 10 p.i. The Ly49G+ NK cell subpopulation had also 
expanded to represent 40% of total NK cells by day 6 p.i. In 
contrast, the frequency of the Ly49L+ NK cell fraction re-
mained unchanged in BALB.By mice, whereas a small but 
significant increase (from 15 to 20% from day 6 p.i.) was ob-
served in BALB/c mice. Ly49L+ NK cell expansion was most 
notable in BALB.K mice, where the frequency of this fraction 
increased to 25 and then 40% from day 4 to 6 p.i. (Fig. 4, D 
and E). Notably, Ly49L+ NK cell expansion was abolished in 
BALB.K mice upon infection with m04 MCMV, suggesting 
that cell proliferation was responsive to the presence of the 
viral m04/gp34 molecule (Fig. 4, D and E; and Fig. S4 D). 
Therefore, NK cell control of viral replication in BALB.K 
mice correlates with the m04/gp34 dependent expansion of 
Ly49L+ NK cells.
Ly49L+ NK cell secretion of IFN- during MCMV infection
In the model of Ly49H-dependent control of MCMV infec-
tion in B6 mice, there is an early nonspecific activation of NK 
cells, which can be detected through NK cell IFN- production. 
There is also a late Ly49H-specific MCMV-dependent phase 
of NK cell activation (Daniels et al., 2001; Dokun et al., 2001). 
To further characterize the impact of H-2 on NK activation 
determined the specificities of available antibodies using the 
reporter cells expressing BALB Ly49 receptors described pre-
viously. The antibodies 14B11 and 4D11 stained Ly49C and 
Ly49G  reporter  cells,  respectively.  The YE1/48  antibody 
stained both Ly49A and Ly49L reporter cells, although Ly49L 
with  lesser  affinity. The  12A8  antibody  specifically  bound 
Ly49A reporter cells. Thus, Ly49A+ cells were defined by   
YE1/48+12A8+  antibody  staining,  and  Ly49L+  cells  as   
YE1/48INT12A8 antibody–stained cells (Fig. 4 A). Using an-
tibody combinations, flow cytometric analysis of fresh NK 
Figure 5.  Preferential IFN- secretion of the Ly49L+ NK cell sub-
population at day 6 p.i. in BALB.K mice. BALB.By, BALB/c, and BALB.K 
mice were infected with 2,500 PFU/mouse of MCMV i.p. At 36 h and 6 d p.
i., the spleens were collected, negatively enriched for NK cells, and acti-
vated with plate-bound -NKp46 and -NKG2D antibody followed by 
CD3, DX5, YE1/48, 12A8, and IFN- staining. Percentages of total IFN-+ 
NK cells gated on CD3DX5+ are shown at 36 h (A) and 6 d (B) p.i.  
(C) Representative contour plots of 12A8YE1/48INTIFN-+ NK cells. Data 
represent one of two experiments performed (mean ± SD) with three to 
four mice per group.
Table II.  Contribution of Ly49L+ NK cells to the production of IFN- 36 h and 6 d p.i. after MCMV infection
Mouse strain and condition tested Percentage of total IFN-+ NK cells Percentage of Ly49L+ NK cells
BALB.By
  Uninfected 1.52 ± 0.40 12.33 ± 3.07
  +MCMV (36 h p.i.) 14.55 ± 2.13 17.33 ± 6.76
  +MCMV (Day 6 p.i.) 2.26 ± 0.24 16.50 ± 1.27
BALB/c
  Uninfected 1.99 ± 0.873 10.69 ± 1.44
  +MCMV (36 h p.i.) 13.60 ± 3.70 13.37 ± 1.18
  +MCMV (day 6 p.i.) 5.4 ± 1.28 23.47 ± 9.00
BALB.K
  Uninfected 1.63 ± 0.79 10.13 ± 2.58
  +MCMV (36 h p.i.) 13.45 ± 4.67 11.65 ± 5.26
  +MCMV (day 6 p.i.) 9.06 ± 2.07 53.6 ± 2.0
In this table, we show the percentage of IFN-–producing NK cells among the total DX5+CD3 splenocyte pool at two different time points after infection (percentage of 
total). The contribution of the Ly49L+ NK cells to the production of IFN- was calculated by dividing the percentage of Ly49L+IFN-+ by the total percentage of IFN-+ NK 
cells. Data represent the percent mean ± SD of three mice per group from one of two experiments performed.JEM VOL. 208, May 9, 2011 
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resistance, which has been associated with the ability of acti-
vating Ly49P receptor to recognize H-2Dk and m04/gp34 on 
the  MCMV-infected  cell,  has  been  described  in  MA/My 
mice (Desrosiers et al., 2005; Kielczewska et al., 2009). Al-
though the involvement of Ly49P was validated in vitro, the 
same cannot be said for in vivo studies because no appropriate 
antibody was available to properly delimit the Ly49P population. 
in the BALB model, we examined NK cell production of 
IFN- at 36 h and 6 d p.i. with MCMV. At the initial time 
point, intracellular staining of IFN- after restimulation re-
vealed a similar frequency of IFN-–producing cells (20%) 
in the BALB.By, BALB/c, and BALB.K strains. Within this 
subset of cells, the Ly49L+ NK fraction represented only a 
minority of total NK cells, that is to say 15% (Fig. 5 A and 
Table II). By day 6 p.i., IFN- production by NK cells de-
creased significantly in all strains, although this decrease was 
the least pronounced in BALB.K mice (Fig. 5). This correlates 
with our observation that Ly49L+ NK cells were the main 
IFN- producers in BALB.K mice. Conversely, the Ly49L+ 
NK cells from BALB/c and BALB.By mice were responsible 
for only a small fraction of IFN- production in these strains, 
although this proportion was significantly higher in BALB/c 
(Fig. 5, B and C; and Table II). Therefore, whereas there is 
nonspecific IFN- production by NK cells at 36 h p.i., pref-
erential IFN- secretion by Ly49L+ NK is observed by day 6 
p.i. after restimulation in BALB.K mice.
Naive Ly49L+ NK cells protect neonate BALB.K mice against 
MCMV infection
The transfer of adult naive Ly49H+ NK cells into neonatal 
mice is sufficient to protect against MCMV infection (Bukowski 
et al., 1985; Sun et al., 2009). Thus, to investigate the protec-
tive potential of Ly49L+ NK cells we used adoptive transfer 
into 3–5-d-old pups 1 d before MCMV infection (Fig. 6 A). 
We  negatively  selected  NK  cells,  sorted  Ly49L+  (YE1/
48INT12A8) or Ly49L (YE1/4812A8) NK cells from adult 
BALB.K female mice, and injected various numbers of each 
cell fraction in pups (Fig. 6 B). Neonates injected with PBS 
alone were used as negative control, whereas transfer of NK 
cells from resistant MA/My mice were used as positive con-
trol. Neonates receiving the Ly49L NK cell fraction were 
not protected and, similar to the PBS-treated group, succumbed 
by day 8 p.i. regardless of the cell number injected (Fig. 6 C 
and not depicted). In contrast, 64% of neonatal mice receiving 
105 NK cells from MA/My survived the infection. Protection 
conferred by Ly49L+ NK cells was dose dependent. Survival 
of infected mice receiving 4 × 104 Ly49L+ NK cell fraction 
was increased by 1 wk compared with 104 NK cell transfer, 
even though none of the neonates survived. Markedly, 40% 
of mice receiving 7 × 104 Ly49L+ NK cells survived 3 wk 
p.i.  (Fig.  6  C).  Finally,  at  the  same  time,  the  transfer  of 
Ly49L+ NK cell fraction significantly reduced viral titers in 
the spleens of neonates compared with Ly49L NK cell 
transfer  or  PBS-injected  controls  (Fig.  6  D). Thus,  the 
Ly49L+ NK cell fraction restricted the viral load and was 
ultimately more protective than Ly49L NK cells against 
MCMV infection.
DISCUSSION
A protective role of Ly49-activating receptor during virus in-
fection has been amply demonstrated in B6 mice, whose NK 
cells  are  activated  through  an  Ly49H–m157  axis  (Lanier, 
2008a). Another NK cell–dependent mechanism of MCMV 
Figure 6.  Adoptive transfer of naive Ly49L+ NK cells into BALB.K 
neonates improves their survival after MCMV infection. (A) Adoptive 
transfer scheme. (B) Sorting gate position and purity. (C) Survival of BALB.K 
neonate mice receiving Ly49L+ NK cells (1 × 104, 4 × 104, or 7 × 104), 
Ly49L NK cells (7 × 104), total MA/My NK cells (1 × 105), or PBS as a 
control, followed by MCMV infection at a dose of 1,000 PFU/pup. Data 
represent four pooled experiments. (D) Viral titers at day 3 p.i. in neonate 
pups transferred with 1 × 105 of either Ly49L+ or Ly49L NK cells or PBS 
only (median viral titer ± IQR). Three pups per condition were tested. Data 
represent one of two experiments performed.1112 NK cell–mediated resistance to MCMV | Pyzik et al.
additional host or pathogen factor is also involved in viral 
recognition by the three receptors described in this paper 
(Kielczewska et al., 2009). Hence, this viral protein might induce 
an allosteric change or cluster H-2 molecules on the surface 
of infected cells, thus allowing a longer and stronger interac-
tion with activating Ly49 receptors. The questions remain of 
which is the additional host or viral molecule in addition to 
m04/gp34 that is necessary to promote recognition of the in-
fected cell by activating Ly49 receptors, and whether it is 
shared by all the receptors. Then again, is it a stress or viral 
peptide  produced  during  infection,  which  is  part  of  the   
H-2Dk–gp34 complex or its presentation by specific H-2 mol-
ecules? Most studies show that Ly49 receptors recognized H-2 
molecules independently of the peptide being presented under 
normal conditions. Yet some receptors might be sensitive to a 
possible peptide-induced allosteric change in H-2 (Correa and 
Raulet, 1995; Orihuela et al., 1996; Hanke et al., 1999).
The prevalence of the m04/gp34-dependent method of 
viral recognition suggests an important role for this viral pep-
tide  in  immunoevasion. We  have  recently  shown  that  the 
m04 virus is attenuated in most susceptible strains, including 
BALB.K, as the protein it encodes abolishes NK cell activa-
tion via the missing-self recognition mechanism (Babić et al., 
2010). Indeed, m04/gp34 escorts MHC class I molecules to 
the surface of infected cells, thus maintaining a level of surface 
MHC expression sufficient enough to trigger several inhibi-
tory NKRs (Kavanagh et al., 2001; Babić et al., 2010). For in-
stance, Ly49A-bearing reporters recognize uninfected cells; 
however, a much stronger, m04-dependent response is observed 
upon co-culture of these reporters with MCMV-infected cells. 
Therefore, in BALB.K mice both activating and inhibitory 
Ly49 receptors are triggered by m04/gp34-H-2 complexes. 
However, as the frequency of Ly49L+ NK cells is low, initially 
the predominant signal is m04-dependent inhibition. In the 
case of m04/gp34 ablation, NK cell inhibition is removed al-
lowing enhanced early control of virus replication even if 
Ly49L+ NK cell activation is also absent.
Our next step was to investigate the role of these three 
activating  receptors  in  vivo.  Experiments  focusing  on  the 
Ly49L receptor were particularly telling. For instance, 15% of 
NK cells in uninfected BALB mice express the activating 
Ly49L receptor.  Yet after MCMV infection, the kinetic analy-
sis of the Ly49 repertoire demonstrated a specific expansion 
of the Ly49L+ NK cell fraction starting at day 4 p.i. in BALB.
K mice, which was not the case in BALB.By mice; in this case, 
BALB/c mice displayed an intermediate phenotype. Interest-
ingly, no such Ly49L+ NK cell proliferation was observed 
upon infection with m04 MCMV, indicating that Ly49L+ 
NK cells need to sense the m04/gp34 product to respond to 
infection. The expansion was correlated with an increased 
ability to control the infection, as well as increased IFN- se-
cretion by H-2k Ly49+ NK cells after day 6 p.i. This was also 
seen in H-2d mice, although to a much lesser extent, and was 
entirely absent in H-2b mice. All in all, these findings demon-
strate that Ly49L+ NK cells in the context of H-2k are   
specifically activated during MCMV infection. In another 
Furthermore, those two Ly49-activating receptors recognize 
infected cells by different mechanisms, raising the question of 
whether a finite number of Ly49-activating receptors is used 
to tackle many different pathogens or whether there is a pref-
erential specificity of certain activating receptors for MCMV. 
Our results revealed that the latter seems to be the case. Re-
porter cells expressing Ly49P1NOD, Ly49LBALB, or Ly49D2PWK 
recognize MCMV-infected MEFs. Remarkably, their mode 
of recognition is H-2 dependent, with a preference for H-2k 
and sometimes for H-2d and H-2f haplotypes, requiring the 
presence of the viral m04/gp34 protein. Thus, these three 
Ly49 haplotype-specific receptors are capable of recognizing 
MCMV infection in an H-2Dk– and m04/gp34-restricted 
manner, along with Ly49P.
Amino acid sequence alignment of the activating Ly49 
receptors assayed in our study has yielded new clues into the 
mechanism of m04/gp34- and H-2–dependent MCMV rec-
ognition. Three residues were found to be conserved among 
activating Ly49 receptors capable of recognizing the infection 
and absent in those that are not: methionine/arginine (M/R) 
at position 223, and leucine (L) and asparagines (N) residues 
at position 234 and 244, respectively. Interestingly, the two 
latter are localized to 3 and 4 sheets, which are predicted 
to be involved in the binding with the H-2 class I molecules. 
Moreover, M/R at position 223 removes an N-glycosylation 
(NTT) site shared by the receptors that do not recognize in-
fection. Previous studies have shown that glycosylation at this 
site affects Ly49 receptor binding to H-2 class I molecules. 
For example, a mutation in Ly49A promoting glycosylation at 
NTT (221–223) prevented H-2Dd tetramer binding, whereas 
alteration of this motif in Ly49D and the subsequent loss of 
glycosylation increased its ability to bind the tetramer (Mason 
et al., 2003). The importance of receptor glycosylation has 
also been observed in T lymphocytes. Indeed, mice deficient 
for the enzyme that performs N-glycosylation have enhanced 
TCR  clustering  and  a  lower  activation  threshold.  During 
CD8+ T cell development, glycosylation of the CD8 -chain 
decreases avidity to H-2 class I molecules (Demetriou et al., 
2001; Moody et al., 2001). Thus, it is possible that lack of a 
functional glycosylation motif facilitates binding of the acti-
vating Ly49 receptors to H-2 class I molecules on MCMV-
infected  cells.  Of  course,  the  specific  involvement  of  the 
M/R223, L234, and N244 residues in the recognition of MCMV-
infected cells will have to be assessed through site-directed 
mutagenesis and direct binding assays of soluble forms of the 
receptors. Nevertheless, the available data suggest that these 
residues are in direct contact with the H-2 class I molecule 
rather than with viral m04/gp34 protein, which remains es-
sential for this mechanism of recognition.
The m04/gp34 protein is thought to stabilize the H-2 on 
the surface of infected cells; however, m04/gp34 has not yet 
been shown to directly interact with activating Ly49 recep-
tors on the surface of infected cells. Furthermore, we have 
previously shown that m04/gp34 is necessary but not suffi-
cient for recognition of infection by Ly49PMA/My-expressing 
reporter cells, yet it remains to be established whether an JEM VOL. 208, May 9, 2011 
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Ly49A+ and/or Ly49G+ NK cells will only receive inhibitory 
signals through these receptors in those two H-2 contexts. 
Therefore, expansion of these NK cell subpopulations—in 
the  H-2b  context  specifically—could  result  in  nonspecific 
NK cell activation. This may be mediated by an inflammatory 
milieu that is not balanced by the inhibitory signals of Ly49A 
and Ly49G in the absence of their ligands. Furthermore, the 
Ly49G+  NK  cell  fraction  has  been  shown  to  expand  in 
C57BL/6 mice upon MCMV, vaccinia virus, mouse hepatitis 
virus, and lymphocytic choriomeningitis virus infection, as 
well as in MA/My mice upon MCMV infection (Daniels   
et al., 2001; Xie et al., 2009; Babić et al., 2010). Moreover the 
increase in this NK fraction could be a negative regulatory 
mechanism to control activation of NK cells.
Even  though  the  protection  against  MCMV  infection 
conferred by Ly49L was restricted to the H-2Dk context, our 
in vitro analysis showed that Ly49L-expressing 2B4 reporter 
cells were able to recognize MCMV infection in the H-2d 
context. BALB/c mice were more resistant than BALB.By 
mice, as shown by the equivalent splenic viral titers at any 
given time point, even though the BALB/c mice were chal-
lenged with twice the viral dose. We also detected an expansion 
of the splenic Ly49L+ NK cell subpopulation, as well as greater 
secretion of IFN- upon restimulation at day 6 p.i. in the 
BALB/c strain. Although it was not the purpose of our study, 
one might speculate that the inhibitory NK cell pathways dif-
fer  among  H-2  congenic  BALB  strains.  Specifically,  the 
threshold of NK cell activation might be higher in BALB.By 
and BALB/c mice than in BALB.K mice as a result of more 
potent and overwhelming pathways of NK cell inhibition. 
Whether this is actually the case remains to be determined.
In addition to Ly49L, other activating receptors were con-
sidered in this study, including Ly49D2, which was isolated 
from the resistant wild-derived strain PWK/Pas. Haplotype 
analysis showed significant similarity between PWK/Pas and 
B6 at Ly49h locus, yet NK cells in PWK/Pas animals were 
negative  for  Ly49H.  Moreover,  PWK/Pas  mice  are  com-
pletely resistant to infection with m157 MCMV, as opposed 
to B6 mice (Adam et al., 2006). However, MCMV resistance 
in PWK/Pas is determined by a major locus, Cmv4, with only 
a small contribution of H-2. Furthermore, the endogenous 
H-2PWK haplotype is the susceptibility allele, and Ly49D2 re-
porter cells are not stimulated in the endogenous H-2PWK back-
ground. All of this suggests the involvement of other receptors 
in  the  resistance  phenotype.  Regardless  of  the  identity  of 
Cmv4, our results indicate the presence of at least one Ly49-
activating receptor in each of the five Ly49 haplotypes capa-
ble of recognition of MCMV infection. It is noteworthy that 
in four examples the mechanism of recognition implicates a 
host class I molecule, indicating that such is a common mech-
anism of Ly49-activating receptor recognition as opposed to 
direct binding to a viral protein as afforded by Ly49H.
Although MCMV recognition is at the core of this paper, 
some activating receptors were found to recognize uninfected 
MEF cells. We identified a new endogenous ligand for the 
Ly49WNOD receptor, H-2f, in addition to the previously 
experiment, adoptive transfer of a Ly49L+ cell fraction signifi-
cantly extended the life span of neonate pups after MCMV 
infection, a protection not seen when a Ly49L fraction was 
transferred. In this assay, naive Ly49L+ NK cells provide in 
vivo control of viral load. Recently, rechallenged NK cells 
have been shown to proliferate better and to secrete more 
IFN- than their naive counterparts (Cooper et al., 2009; Sun 
et al., 2009). In an adoptive transfer experiment, low numbers 
of rechallenged NK cells provided protection from MCMV, 
whereas naive NK cells did not. A dose-dependent protection 
by the naive Ly49L+ NK cells can also be seen; indeed, the 
transfer of 7 × 104 of those cells was able to improve mice 
survival to the same extent as a transfer of 105 total naive NK 
cells from resistant MA/My mice. Therefore, the transfer of 
Ly49L+ NK cells isolated from mice previously infected with 
MCMV (i.e., memory NK cells) could provide better protec-
tion to neonate mice than the transfer of naive NK cells. Col-
lectively these results point to a central role of the activating 
Ly49L receptor in the control of viral spread. By analogy with 
the response of Ly49H+ NK cells during infection, one possi-
ble interpretation of these results is that Ly49L+ NK cells are 
being  activated  through  a  Ly49L–m04/gp34–H-2Dk  axis, 
leading to elimination of MCMV-infected cells.
Despite having an activating receptor capable of recogniz-
ing the infection, viral titers in the spleen of BALB.K mice are 
elevated during the initial phase of the infection. This could 
be a result of three important facts. First, the Ly49L+ NK cell 
population is small in the absence of infection, only account-
ing for 15% of total splenic NK cells. Therefore, the initial 
inability of BALB.K to control MCMV proliferation could 
simply be the result of an insufficient number of effector cells. 
In comparison, 28% of splenic NK cells express Ly49H in 
Tg915 mice (transgenic for Ly49H). This is enough to make 
them significantly less resistant to MCMV infection than B6 
mice, in which 50% of total splenic NK cells are Ly49H+ (Lee 
et al., 2003). Second, surface expression of m04/gp34 is de-
pendent on its association with H-2, yet H-2 is rapidly mod-
ulated by other viral immunoevasins such as m152/gp40 and 
m06/gp48, which, respectively, retain it in the cis-Golgi com-
partment of the endoplasmic reticulum or redirect it to endo-
some–lysosome  pathway  for  degradation  (Kleijnen  et  al., 
1997; Ziegler et al., 1997). This can limit the amount of avail-
able ligand with which Ly49L can interact. In contrast, m157, 
the ligand for Ly49H, is ubiquitously expressed starting at 4 h 
p.i. Third, competition with other inhibitory Ly49 receptors 
expressed on the same NK cell (e.g., Ly49C and Ly49G) 
could alleviate activation mediated by Ly49L+ NK cells (Babić 
et al., 2010). These inhibitory signals might overcome Ly49L 
signaling and drive the NK cell to unresponsiveness rather 
than activation. At later time points, though, the specific ex-
pansion of Ly49L+ NK cells may amplify the activating signal 
to a point where it overwhelms inhibition and induces NK 
cell activation, which also serves to initiate the adaptive im-
mune response.
Ly49G and Ly49A are known to bind to H-2Dk and H-
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experiments were approved by the Canadian Council on Animal Care and the 
McGill University Animal Resources Center. Unless otherwise specified, all 
animals were between 8 and 10 wk of age. Donor mice were 8–12 wk old.
Cloning. Ly49H, Ly49C, Ly49P, Ly49U, and Ly49R reporter cells were gen-
erated as previously described (Kielczewska et al., 2009). Ly49A, Ly49D, and 
Ly49G  from  C57BL/6,  Ly49A,  Ly49L,  and  Ly49G  from  BALB,  Ly49P, 
Ly49M, Ly49D, and Ly49W from NOD/Ltj, and Ly49D1 and Ly49D2 from 
PWK/Pas were cloned into pMx-puromycin vectors using specific primers 
(Table S1) as previously described (Arase et al., 2002). 2B4 reporter cells were 
generated as previously described (Fodil-Cornu et al., 2010). Chimera pro-
tein receptors were generated by joining the NKD from each aforemen-
tioned  inhibitory  Ly49  to  the  backbone  (cytoplasmic/transmembrane 
[TM]/stalk: CTS) of activating Ly49H as described by Kielczewska et al. 
(2007). The  CD3-Ly49ATM-NKR-P1A  construct  was  a  gift  from W.H.   
Yokoyama  (Washington  University  School  of  Medicine,  St.  Louis,  MO).   
Using this, a Ly49A-CD3 chimera was generated in a threefold manner. 
First, the CD3 and the Ly49A NKD-stalk domain were amplified by PCR 
from their respective vectors. Specific primers that also allowed the partial 
amplification of the Ly49A TM domain in each construct (located in the   
5 end and in the 3 end for the CD3 and Ly49A constructs, respectively) 
and the addition of an Esp3I restriction site were used. Second, both PCR 
products were digested with Esp3I and ligated (Thermo Fisher Scientific) 
together as follows: CD3-Ly49ATM-Esp3I and Esp3I-Ly49ATM/Stalk/NKD  
(ligation site in the Ly49A TM domain).
Virus stocks, mouse infections, and virus titration. The Smith strain of 
MCMV was obtained from the American Type Culture Collection. Salivary 
gland stocks were prepared by propagation in 3-wk-old BALB/c mice as 
previously described (Desrosiers et al., 2005). 7–8-wk-old mice were injected 
i.p. with 5 × 103 or 2.5 × 103 PFU/mouse of MCMV or tissue culture 
grown 5 × 105 PFU/mouse of m04 MCMV. Viral titers in various organs 
were assessed by plaque assay as previously described (Desrosiers et al., 2005). 
For NK and/or CD8 T cell depletion experiments, mice were injected i.v. 
with either 30 µl -asialo-GM1 (Wako Chemicals USA) or 250 µg -CD8 
mAb (clone: H35-17.2.4; gift from M. Pierres, Centre d’Immunologie de 
Marseille-Luminy, Marseille, France) 48 h before infection. Viral titers were 
assessed at days 4 and 6 p.i. To assess viral titers at day 10, mice were injected 
one additional time at day 4 p.i. As plaque assays were performed, depletion 
was assessed by FACS. The m04, m04m06m152, and WT BAC-derived 
(MW97.01) viruses were previously described (Wagner et al., 1999).
Flow cytometry, NK cell enrichment, and sorting. Antibodies used 
were the following: NKp46 (29A1.4; FITC, PE, or Alexa Fluor 647 conju-
gated; eBioscience), Pan-NK cells (DX5; FITC, PE, or Alexa Fluor 647 con-
jugated; eBioscience), Ly49A (YE1/48; FITC, PE, or biotin conjugated and 
purified; BioLegend), Ly49A/D (12A8; PE conjugated; eBioscience), Ly49G 
(4D11; FITC or PerCP-eFluor710 conjugated; eBioscience), Ly49G (AT8; 
PE conjugated; eBioscience), Ly49C (14B11; FITC or biotin conjugated; 
eBioscience), Flag-M2 (Sigma-Aldrich), donkey -mouse IgG (polyclonal; 
PE conjugated; eBioscience), IFN- (XMG1.2; PerCP-Cy5.5 conjugated; 
eBioscience),  CD3  (145-2C11;  PerCP-Cy5.5  conjugated;  eBioscience), 
CD8 (53–6.7; FITC or PE conjugated; eBioscience), TCR- (H57-597; 
FITC  conjugated;  eBioscience),  H-2Dk  (15–5-5;  unconjugated  or  FITC 
conjugated; eBioscience), H-2Dd (34–2-12S; FITC conjugated; eBioscience), 
H-2Kd (SF1-1.1; FITC conjugated; eBioscience), H-2Kk (36–7-15; unconju-
gated or FITC conjugated; eBioscience), IgG2a isotype control (biotin con-
jugated; eBioscience), and streptavidin (FITC, PE, APC, PerCP-Cy5.5, or 
eFluor450 conjugated; eBioscience). Spleens from infected mice were col-
lected in 4 ml of 2% DME and macerated with cell strainers. 3/4 of the sam-
ple was used to assess the viral titer via plaque assay, and 1/4 was treated with 
Ack’s lysis buffer, washed in cold PBS, and stained for various specific surface 
markers. In particular, the best demarcation of the Ly49L+ NK cell fraction 
was seen after surface staining and a mild 15-min fixation in 4% paraformal-
dehyde (Stewart et al., 2007).
identified H-2Dk and H-2Dd molecules (Kane et al., 2001). 
Thus,  although  Ly49W-expressing  reporter  cells  were  not 
stimulated by H-2g7 MEFs, the endogenous NOD H-2 hap-
lotype, autoimmunity or anergy could result from having an 
activating NKR with affinity for a cognate self–H-2 mole-
cule. Recently, it has been shown that anergy is the most 
likely outcome. For instance, chimeric mice constitutively ex-
pressing m157 display hyporesponsive Ly49H+ NK cells after 
MCMV  infection  (Sun  and  Lanier,  2008; Tripathy  et  al., 
2008). However, the physiological relevance and the func-
tional role of the activating Ly49W receptor, capable of bind-
ing to self H-2 molecules, need to be further studied, namely 
in NOD mice congenic for H-2k or H-2f. Nevertheless, it 
seems that the impact of Ly49W on NK cell homeostasis 
would not be affected in NOD mice.
The present study has improved our grasp of NK cell–
mediated recognition of MCMV in a mouse model. Un-
doubtedly, parallels can be made with HCMV infection in 
humans. However, KIRs, which have a homologous function 
to  Ly49  receptors,  have  not  been  directly  implicated  in 
HCMV-infected cell recognition. Yet NK cell involvement is 
undeniable. For instance, individuals with NK cell deficien-
cies  are  hypersusceptible  to  infection  with  herpesviruses, 
HCMV among them (Biron et al., 1989; Orange et al., 2002). 
Furthermore,  HCMV  seropositive  patients  have  increased 
circulating levels of NKG2C+ NK cells compared with un-
infected individuals; upon in vitro co-culture with HCMV-
infected fibroblasts, the NKG2C+ NK cell fraction specifically 
proliferates (Gumá et al., 2004, 2006). Moreover, a signifi-
cantly reduced risk of HCMV reactivation was reported in 
sibling transplantations where the donor had more than one 
activating KIR (Cook et al., 2006). Individuals with different 
KIR repertoires respond differentially to infection with other 
viruses such as HIV. For example, the activating KIR3DS1 
receptor mediates host protection to HIV infection when its 
ligand HLA-Bw4-80I is expressed on infected cells (Martin 
et al., 2002). KIR3DS1+ NK cells were also shown to specifi-
cally expand during acute HIV-1 infection given the presence 
of HLA-B Bw4-80I (Alter et al., 2009).
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